Opiate Dependence
Conditions
Keywords
opiate dependence, buprenorphine
Brief summary
The purpose of this study was to expand access to buprenorphine using a mobile health care system among marginalized populations with or at high risk for HIV and observe longitudinal effects of treatment.
Interventions
OTHERMobile Access
Subjects would access buprenorphine through mobile access. On day 1: 8 mg of buprenorphine, then on Day 2: 16 mg daily of buprenorphine sublingually.
Sponsors
Yale University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* HIV + * At high risk for HIV (IV drug use, commercial sex worker, partner of HIV+) * Mental Health (unmanaged or diagnosed mental illness)
Exclusion criteria
* Benzodiazepine use * Opiate use due to pain management issues only (present or past) * Non-IDU
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Attendance | 10/1/03-9/30/08 | To assess the feasibility and efficacy of the use of buprenorphine to treat opioid dependence in high risk populations accessing a mobile health care system using tracked attendance. |
| Opioid free urine toxicology | 10/1/03-9/30/08 | To assess the feasibility and efficacy of the use of buprenorphine to treat opioid dependence in high risk populations accessing a mobile health care system using incidence of opioid free urine toxicology. |
Secondary
| Measure | Time frame |
|---|---|
| Access to other health care, incarceration, hospitalization acceptability of the site of care from both patient and provider perspectives, and attendance and adherence to counseling. | 10/1/03-9/30/08 |
Countries
United States
Outcome results
None listed